Trader Note — 9342 total
CRVS enters July with a striking contradiction at its core: the stock has rallied 18% in a week and 20% over the past month to close at $14.94, yet short sellers have not retreated — they have added to positions. Short…
BeOne Medicines enters July with short sellers voting heavily with their feet — and the borrow market confirming there's almost no conviction left on the bearish side. Short interest has collapsed over the past month,…
Altimmune enters July with one of the most heavily shorted positions in small-cap biotech, even as the stock edges higher and insiders continue to put their own money in. Short interest is the defining story here, and…
SPCX at $170.86 is a stock with a $190 bull target, a $115 bear target, and a Nasdaq 100 rebalance landing in two days — the Street's first week of formal coverage has produced no consensus whatsoever. The analyst…
HUBB heads into its July 28 earnings date with shorts quietly rebuilding, borrowing costs climbing, and the stock trading near all-time highs — a combination that makes the setup worth watching. Short interest has been…
Ferrari heads into the final trading day of June with a rare combination: a 7.5% weekly gain while virtually every close peer finished in the red. That divergence is the story. Porsche fell 6.3% on the week. Volkswagen…
LivaNova heads into its July 29 earnings date with short sellers quietly adding pressure after a strong month for the stock. The most notable tension this week is the divergence between price and positioning. LIVN…
XLRE closes out the first half of 2026 with a fresh tension: short interest has nudged back up over the past week even as the borrow market continues to loosen — a split that is worth watching as the fund slips back…
Chemours enters July with short sellers adding pressure and the Street trimming targets, even as the stock stages a modest recovery from last week's selloff. The most notable development this week is that short…
ABIVAX's ABVX stock exploded 39% on June 30, its biggest single-session move in months, yet the lending market tells a story of shorts who aren't backing down. The catalyst appears to be continued momentum around the…
Glaukos Corporation enters the final stretch of Q2 with a sharp and unusual divergence: short sellers have rebuilt positions aggressively over the past month, yet the options market just flipped to its most bullish…
BRSL enters the final stretch before its July 28 earnings with a notable shift in the analyst narrative — a fresh Deutsche Bank buy initiation arriving just as the extreme options defensiveness flagged last week has…
S32 heads into its July 20 production report carrying its worst monthly loss in recent memory, with the stock down 19% over the past month to AUD 3.90, while most of its peer group has also been under heavy selling…
Equinix enters the final stretch of Q2 with a sharp price reversal, a put/call ratio brushing its highest level of the year, and a Street consensus that still sees meaningful upside — a tension between defensive…
Cloudflare closes the week at $245.28 — up 9% — yet its options market just printed the most defensive reading of the past year, a tension that has now persisted and deepened across three consecutive weekly notes. The…
Axalta Coating Systems heads into the final session of June with shorts exiting, analyst confidence rebuilding, and options markets leaning firmly bullish — a notably cleaner setup than the stock carried a month…
FRPT ends the week with a sharp recovery that puts its bearish positioning under fresh scrutiny — the stock is up 11% in five sessions to $59.12, even as shorts hold nearly one-fifth of the float and BofA trimmed its…
CRON closed the week at CAD 3.92, up 2.9% over five days, but the more interesting move was happening in the lending market — where the cost to borrow the stock has nearly doubled in a month against a backdrop of…
Alibaba enters July with the stock down another 6.5% on the week to $95.98 — extending a brutal month that has now erased roughly 23% — yet the options market is flashing an unusually constructive signal against that…
Dorian LPG enters the first week of July having shed 14% in five sessions — a bruising decline that lands the stock back near $34.78, close to where its CEO bought shares in January. The most striking dynamic this week…
